Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm. (Q36133383)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27629776 AND SRC:MED&resulttype=core&format=json

23 March 2020

review article

1 reference

title

Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27629776 AND SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

1

Eduard Shantsila

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27629776 AND SRC:MED&resulttype=core&format=json

23 March 2020

2

Gregory Yh Lip

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27629776 AND SRC:MED&resulttype=core&format=json

23 March 2020

language of work or name

English

0 references

publication date

15 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27629776 AND SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

23 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27629776 AND SRC:MED&resulttype=core&format=json

23 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27629776 AND SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

CD003333

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27629776 AND SRC:MED&resulttype=core&format=json

Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study

23 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Antiplatelet Agents and Survival: A Cohort Analysis From the Studies of Left Ventricular Dysfunction (SOLVD) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Effect of antithrombotic therapy on risk of sudden coronary death in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Heart failure and the risk of stroke: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Anticoagulation versus placebo for heart failure in sinus rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Venous Thromboembolism in Heart Failure: Preventable Deaths During and After Hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Preventing Thrombosis to Improve Outcomes in Heart Failure Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Stroke in patients with heart failure and reduced left ventricular ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

The incidence of ischemic stroke in chronic heart failure: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003333.PUB3

Population impact of heart failure and the most common forms of cancer: a study of 1 162 309 hospital cases in Sweden (1988 to 2004).

21 January 2018

1 reference

12 December 2020

Disease burden and unmet needs for prevention of venous thromboembolism in medically ill patients in Europe show underutilisation of preventive therapies

1 reference

12 December 2020

Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin

1 reference

12 December 2020

Antiplatelet agents in the secondary prevention of stroke: meta-analysis of the randomized control trials

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group

1 reference

12 December 2020

Ventricular dysfunction and the risk of stroke after myocardial infarction

1 reference

12 December 2020

Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts

1 reference

12 December 2020

10.1002/14651858.CD003333.PUB3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27629776 AND SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27629776 AND SRC:MED&resulttype=core&format=json

23 March 2020

PubMed publication ID

27629776

1 reference